Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies on chemically modified fibrinogen

M Kloczewiak, Z Wegrzynowicz, F R Matthias

    Thrombosis and Haemostasis
    |April 30, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Persistent angina pectoris in spite of successful myocardial revascularisation].

    Zeitschrift fur Kardiologie·2004
    Same author

    The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.

    Thrombosis and haemostasis·2002
    Same author

    Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.

    Annals of the New York Academy of Sciences·2001
    Same author

    Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife.

    Thrombosis and haemostasis·2001
    Same author

    The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.

    Thrombosis and haemostasis·2001
    Same author

    Increase in platelet count in response to rHuEpo in a patient with thrombocytopenia and absent radii syndrome.

    Blood·2001

    Maleic acid anhydride treatment makes fibrinogen unclottable by inhibiting fibrin monomer polymerization. This modification, increasing negative charges, prevents clot formation without affecting fibrinopeptide release.

    Area of Science:

    • Biochemistry
    • Hematology
    • Protein Chemistry

    Background:

    • Fibrinogen is a key protein in blood coagulation.
    • Understanding fibrinogen modification is crucial for studying clotting disorders.

    Purpose of the Study:

    • To investigate the effects of maleic acid anhydride modification on fibrinogen's clotting ability.
    • To elucidate the mechanism behind the induced incoagulability.

    Main Methods:

    • Radioactive labeling studies to track fibrinopeptide release.
    • Discelectrophoresis to analyze protein fragments after plasmic digestion.
    • Functional assays to assess polymerization inhibition.

    Main Results:

    • Maleic acid anhydride-treated fibrinogen became unclottable.

    Related Experiment Videos

  • Fibrinopeptide release by thrombin or reptilase remained unaffected.
  • Incoagulability resulted from inhibited fibrin monomer polymerization due to increased negative charges.
  • Modified fibrinogen did not yield D and E fragments upon plasmic digestion but degraded into high molecular weight products.

    • Conclusions:

    • Maleic acid anhydride modification effectively inhibits fibrinogen polymerization, leading to incoagulability.
    • The mechanism involves increased electronegative charges on the fibrinogen molecule.
    • Modified fibrinogen exhibits functional similarities to abnormal fibrinogens seen in dysfibrinogenemia.